AmplifyBio scoops up lab space and other assets from PACT Pharma as cell therapy biotech readjusts

The West Coast cell therapy biotech PACT Pharma was facing some challenges after several employees got the axe from the company and execs put the kibosh on its only clinical trial. Now, the company has sold some of its assets to an Ohio-based contract research organization.

AmplifyBio has…